benzyl (S)-1-((S)-2-(((S)-1-fluoro-6-guanidino-2-oxohexan-3-yl)(methyl)carbamoyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-ylcarbamate

ID: ALA4575136

Chembl Id: CHEMBL4575136

PubChem CID: 155560932

Max Phase: Preclinical

Molecular Formula: C26H39FN6O5

Molecular Weight: 534.63

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)CF

Standard InChI:  InChI=1S/C26H39FN6O5/c1-17(2)22(31-26(37)38-16-18-9-5-4-6-10-18)24(36)33-14-8-12-20(33)23(35)32(3)19(21(34)15-27)11-7-13-30-25(28)29/h4-6,9-10,17,19-20,22H,7-8,11-16H2,1-3H3,(H,31,37)(H4,28,29,30)/t19-,20-,22-/m0/s1

Standard InChI Key:  AZFISXVARSLZRE-ONTIZHBOSA-N

Alternative Forms

  1. Parent:

    ALA4575136

    ---

Associated Targets(Human)

OCI-Ly3 (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MALT1 Tchem Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (705 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OCI-Ly1 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 534.63Molecular Weight (Monoisotopic): 534.2966AlogP: 1.56#Rotatable Bonds: 13
Polar Surface Area: 157.92Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.37CX Basic pKa: 11.97CX LogP: 1.22CX LogD: -1.02
Aromatic Rings: 1Heavy Atoms: 38QED Weighted: 0.17Np Likeness Score: -0.38

References

1. Hatcher JM, Du G, Fontán L, Us I, Qiao Q, Chennamadhavuni S, Shao J, Wu H, Melnick A, Gray NS, Scott DA..  (2019)  Peptide-based covalent inhibitors of MALT1 paracaspase.,  29  (11): [PMID:30954428] [10.1016/j.bmcl.2019.03.046]

Source